Biotech entity
pharma is the sole category represented across all 2 tracked stories. Of the tracked stories, 1 of 2 also mention Brian Christine, the most common co-covered peer. That works out to roughly 0.7 stories per week across a 21-day span.
Last mentioned: Feb 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 2 tracked stories. Of the tracked stories, 1 of 2 also mention Brian Christine, the most common co-covered peer. That works out to roughly 0.7 stories per week across a 21-day span. At 7, the average consequence score sits above the same-window beat average of 6. Source depth averages 2.5 original sources per story, versus 3.3 across the same-window beat baseline. This profile follows 2 Biotech stories mentioning NIH across the period from February 20, 2026 to March 12, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 234 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NIH. Shared-story counts are live from our verified record — not editorial picks.
Clinical Guidance
Expected release of preliminary federal protocols for detransition medical management.
Regulatory Review
Anticipated commencement of HHS review into federal funding for gender-affirming clinics.
Policy Announcement
Assistant Secretary Brian Christine declares detransition care a top priority for HHS.
Dual-Leadership Confirmed
International sources confirm Bhattacharya will lead both agencies, highlighting the strategic consolidation of health oversight.
CDC Appointment Announced
Reports emerge that NIH Director Dr. Jay Bhattacharya will take over as acting head of the CDC.
HHS Assistant Secretary Brian Christine has announced that detransition care will become a primary focus for the department, marking a significant pivot in federal healthcare policy. This shift is expected to influence clinical guidelines, pharmaceutical regulation, and federal funding for gender-related medical interventions.
NIH Director Dr. Jay Bhattacharya has been appointed as the acting head of the CDC, creating a historic dual-leadership role over the two most powerful U.S. health agencies. This consolidation marks a significant shift in public health strategy, placing research and implementation under a single executive.
NIH is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
